CD4 and breast carcinoma: In addition, Th2 cell immunity plays a critical role in regulating tumor development, and depletion of Transforming Growth Factor (TGF)-β receptors on CD4+ T cells, but not CD8+ T cells, which can halt tumor progression in breast cancer (Liu et al., 2020).